Management of screen detected ductal carcinoma in situ of the female breast
โ Scribed by Mr. R. Carpenter; P. S. Boulter; T. Cooke; N. M. Gibbs
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 417 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr
Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering
agree with the authors that an adequate surgical event, unrelated to the skill of the pathologist who selects the block to be used for frozen section. margin is the most important factor affecting the prognosis for survival and local recurrence. The article also men-I suggest that this entrenched te
Hospitals of RESULTS. FS examination was performed on 153 cases (85%) and only macroscopic Cleveland, Cleveland, Ohio. examination on 28 cases (15%). FS diagnoses were as follows: DCIS in 76 cases 2 Ireland Cancer Center and Department of Epi-(50%), atypical ductal hyperplasia/suspicious for DCIS in
MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought